A study to assess the effect of modified form of Chandanadi bidalaka (external application)as an add on therapy with Mridweekadi Arka Aschyotana(instillation)in reducing the ocular symptoms of computer vision syndrome like redness,watering and light sensitivity comparing to the aschyotana alone.

Add on effect of value-added formulation of chandanadi bidalaka with mridweekadi arka aschyotana in computer vision syndrome - a comparative study - NIL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102105

Enrollment

Registered

2026-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H531- Subjective visual disturbances

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Those who are exposed to screentime more than or equal to 4 hrs Symptoms of CVS specifically burning sensation, redness , sensitivity of light and prfouse watering of eyes

Exclusion criteria

Exclusion criteria: 1.Ocular allergic conditions and Ocular injuries 2.Corneal ulcer 3. Contact lens users 4.Known cases of glaucoma and diabetes mellitus and other systemic illness 5.Subjects who have undergone any surgeries in eye 6.Those who are taking steroids 7. Systemic diseases leading to dry eye Sjogren s syndrome 8. One eye patient 9. Those who are already under treatment for dry eyes 10. Ophthalmic pathologies other than CVS

Design outcomes

Primary

Measure	Time frame
compare the effect of value-added form of Chandanadi bidalaka as an add on therapy with Mridweekadi Arka Aschyotana in reducing the ocular manifestation of computer vision syndrome specifically redness, burning sensation, profuse watering and intolerance to light. assess the immediate relief in the ocular manifestation of computer vision syndrome with the application of Value-added form of Chandanadi bidalaka comparing to the Mridweekadi aschyotana alone. Subjective parameters 1. CVS Questionnaire and OSDI score 2. Relief of symptoms specifically burning sensation, redness, profuse watering, sensitivity to light Objective parameters 1.Schirmer-1 test 2.Tear film break up timeTimepoint: The patient will be assessed on 0th ,8 th and 16Th day of treatment . The relief of symptoms specifically the redness, burning sensation, intolerance to light and profuse watering will be assessed on the 8th day with the CVS questionnaire and OSDI score. On the 16th day the subjective parameters and the Objective parameters including the Schirmer-1 test and Tear film break up time will be assessed.	—

Measure

Time frame

compare the effect of value-added form of Chandanadi bidalaka as an add on therapy with Mridweekadi Arka Aschyotana in reducing the ocular manifestation of computer vision syndrome specifically redness, burning sensation, profuse watering and intolerance to light. assess the immediate relief in the ocular manifestation of computer vision syndrome with the application of Value-added form of Chandanadi bidalaka comparing to the Mridweekadi aschyotana alone. Subjective parameters 1. CVS Questionnaire and OSDI score 2. Relief of symptoms specifically burning sensation, redness, profuse watering, sensitivity to light Objective parameters 1.Schirmer-1 test 2.Tear film break up timeTimepoint: The patient will be assessed on 0th ,8 th and 16Th day of treatment . The relief of symptoms specifically the redness, burning sensation, intolerance to light and profuse watering will be assessed on the 8th day with the CVS questionnaire and OSDI score. On the 16th day the subjective parameters and the Objective parameters including the Schirmer-1 test and Tear film break up time will be assessed.

—

Secondary

Measure	Time frame
evaluate the relief of ocular manifestation with subjective parameters including OSDI score and CVS questionnaire and objective parameters including Schirmer-1 test and Tear film break up time.Timepoint: The patient will be assessed on 0th ,8 th and 16Th day of treatment . The relief of symptoms specifically the redness, burning sensation, intolerance to light and profuse watering will be assessed on the 8th day with the CVS questionnaire and OSDI score. On the 16th day the subjective parameters and the Objective parameters including the Schirmer-1 test and Tear film break up time will be assessed.	—

Measure

Time frame

evaluate the relief of ocular manifestation with subjective parameters including OSDI score and CVS questionnaire and objective parameters including Schirmer-1 test and Tear film break up time.Timepoint: The patient will be assessed on 0th ,8 th and 16Th day of treatment . The relief of symptoms specifically the redness, burning sensation, intolerance to light and profuse watering will be assessed on the 8th day with the CVS questionnaire and OSDI score. On the 16th day the subjective parameters and the Objective parameters including the Schirmer-1 test and Tear film break up time will be assessed.

—

Countries

India

Contacts

Public ContactDr Aiswarya Unnikrishnan

Govt. Ayurveda College , Thripunithra

drsreekumarmsayu@yahoo.co.in9447295858

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026

A study to assess the effect of modified form of Chandanadi bidalaka (external application)as an add on therapy with Mridweekadi Arka Aschyotana(instillation)in reducing the ocular symptoms of computer vision syndrome like redness,watering and light sensitivity comparing to the aschyotana alone.

Conditions

Related papers

Interventions

Sponsors

Eligibility

Inclusion criteria

Exclusion criteria

Design outcomes

Primary

Secondary

Countries

Contacts

Outcome results